• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes.偶然发现的无功能胰腺内分泌肿瘤的影响:患者的短期和长期预后
Arch Surg. 2011 May;146(5):534-8. doi: 10.1001/archsurg.2011.102.
2
Incidentally, it's still cancer.顺便说一句,这仍然是癌症。
Arch Surg. 2011 May;146(5):539. doi: 10.1001/archsurg.2011.105.
3
Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors.保留胰腺实质的小型无功能性胰腺内分泌肿瘤切除术。
Ann Surg Oncol. 2010 Jun;17(6):1621-7. doi: 10.1245/s10434-010-0949-8. Epub 2010 Feb 17.
4
Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?腹腔镜切除术对胰腺神经内分泌肿瘤患者是否足够?
World J Surg. 2008 May;32(5):904-17. doi: 10.1007/s00268-008-9467-2.
5
Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.晚期神经内分泌肿瘤患者进行积极手术切除的发病率和死亡率。
Arch Surg. 2003 Aug;138(8):859-66. doi: 10.1001/archsurg.138.8.859.
6
Resection of pancreatic neuroendocrine tumors: results of 70 cases.胰腺神经内分泌肿瘤切除术:70例病例结果
Arch Surg. 2006 Aug;141(8):765-9; discussion 769-70. doi: 10.1001/archsurg.141.8.765.
7
Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.胰腺无功能性神经内分泌肿瘤的手术经验
Am Surg. 2000 Dec;66(12):1116-22; discussion 1122-3.
8
Sporadic nonfunctioning pancreatic neuroendocrine tumors: prognostic significance of incidental diagnosis.散发性无功能性胰腺神经内分泌肿瘤:偶然诊断的预后意义。
Surgery. 2014 Jan;155(1):13-21. doi: 10.1016/j.surg.2013.08.007. Epub 2013 Nov 12.
9
Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors.预测无功能性胰腺神经内分泌肿瘤的侵袭性行为。
Surgery. 2013 Oct;154(4):785-91; discussion 791-3. doi: 10.1016/j.surg.2013.07.004.
10
Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters.1型多发性内分泌腺瘤相关胰腺神经内分泌肿瘤手术后的预后:功能很重要。
Surgery. 2021 Apr;169(4):963-973. doi: 10.1016/j.surg.2020.09.037. Epub 2020 Nov 19.

引用本文的文献

1
Surgical vs. Conservative Management of Patients with Nonfunctioning Pancreatic Neuroendocrine Tumors Smaller than 2 cm (NF-PANNETs < 2 cm) Systematic Review and Meta-Analysis.小于2厘米的无功能性胰腺神经内分泌肿瘤(NF-PANNETs < 2 cm)患者的手术治疗与保守治疗:系统评价和荟萃分析
Cancers (Basel). 2025 May 13;17(10):1649. doi: 10.3390/cancers17101649.
2
Characteristics and outcomes of observed versus resected pancreatic neuroendocrine tumors.观察性与切除性胰腺神经内分泌肿瘤的特征及预后
Proc (Bayl Univ Med Cent). 2025 Feb 18;38(3):213-219. doi: 10.1080/08998280.2025.2463289. eCollection 2025.
3
Management of patients with small pancreatic neuroendocrine tumors from a biomarker and surgical perspective.从生物标志物和手术角度看小胰腺神经内分泌肿瘤患者的管理
Endocr Relat Cancer. 2025 Apr 4;32(5). doi: 10.1530/ERC-24-0305. Print 2025 May 1.
4
Somatostatin Analogs Versus Active Surveillance in Small Pancreatic Neuroendocrine Tumors.生长抑素类似物与小胰腺神经内分泌肿瘤的主动监测对比
Pancreas. 2025 Jul 1;54(6):e524-e529. doi: 10.1097/MPA.0000000000002425.
5
Diagnostic and prognostic biomarkers for pancreatic neuroendocrine neoplasms.胰腺神经内分泌肿瘤的诊断和预后生物标志物
Pathologie (Heidelb). 2024 Nov;45(Suppl 1):74-82. doi: 10.1007/s00292-024-01393-8. Epub 2024 Nov 18.
6
Preoperative Prediction of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors Using a Combined CT Radiomics-Clinical Model.使用 CT 影像组学-临床联合模型预测无功能性胰腺神经内分泌肿瘤的淋巴结转移。
Ann Surg Oncol. 2024 Nov;31(12):8136-8145. doi: 10.1245/s10434-024-16064-4. Epub 2024 Aug 23.
7
Prospective study on stereotactic body radiotherapy for small pancreatic neuroendocrine tumors: tolerance and effectiveness analysis.立体定向体部放疗治疗小胰腺神经内分泌肿瘤的前瞻性研究:耐受性与疗效分析
Clin Transl Oncol. 2025 Jan;27(1):377-385. doi: 10.1007/s12094-024-03538-w. Epub 2024 Jun 22.
8
Developing a Predictive Model for Metastatic Potential in Pancreatic Neuroendocrine Tumor.建立胰腺神经内分泌肿瘤转移潜能的预测模型。
J Clin Endocrinol Metab. 2024 Dec 18;110(1):263-274. doi: 10.1210/clinem/dgae380.
9
Pancreatic neuroendocrine tumors: Are tumors smaller than 2 cm truly indolent?胰腺神经内分泌肿瘤:直径小于2厘米的肿瘤真的是惰性的吗?
World J Gastrointest Oncol. 2024 May 15;16(5):1756-1762. doi: 10.4251/wjgo.v16.i5.1756.
10
Impact of Regional Metastasis on Survival for Patients with Nonfunctional Pancreatic Neuroendocrine Tumors: A Systematic Review.区域性转移对无功能性胰腺神经内分泌肿瘤患者生存的影响:系统评价。
Ann Surg Oncol. 2024 Aug;31(8):4976-4985. doi: 10.1245/s10434-024-15249-1. Epub 2024 Apr 23.

本文引用的文献

1
Surgical management of pancreatic endocrine tumors.胰腺内分泌肿瘤的外科治疗
Nat Rev Clin Oncol. 2009 Jul;6(7):419-28. doi: 10.1038/nrclinonc.2009.82. Epub 2009 Jun 9.
2
Current trends in pancreatic cystic neoplasms.胰腺囊性肿瘤的当前趋势
Arch Surg. 2009 May;144(5):448-54. doi: 10.1001/archsurg.2009.36.
3
The outcomes after surgical resection in pancreatic endocrine tumors: an institutional experience.胰腺内分泌肿瘤手术切除后的结局:一项机构经验
Eur J Surg Oncol. 2009 Jul;35(7):728-33. doi: 10.1016/j.ejso.2009.01.006. Epub 2009 Feb 1.
4
Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.胰腺神经内分泌肿瘤:手术切除对生存的影响。
Cancer. 2009 Feb 15;115(4):741-51. doi: 10.1002/cncr.24065.
5
Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors.改善胃肠胰神经内分泌肿瘤管理的优先事项。
J Natl Cancer Inst. 2008 Sep 17;100(18):1282-9. doi: 10.1093/jnci/djn275. Epub 2008 Sep 9.
6
Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry.胰腺肿瘤发病率的变化:对全州肿瘤登记处的16年回顾
Pancreas. 2008 Aug;37(2):134-8. doi: 10.1097/MPA.0b013e318163a329.
7
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.一种新型TNM分类系统对上消化道胰腺神经内分泌肿瘤的预后相关性
Cancer. 2008 Jul 15;113(2):256-65. doi: 10.1002/cncr.23549.
8
Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients.预测胰腺神经内分泌肿瘤切除术后生存的预后评分:3851例患者分析
Ann Surg. 2008 Mar;247(3):490-500. doi: 10.1097/SLA.0b013e31815b9cae.
9
Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.胰腺神经内分泌肿瘤的检测模式及预后演变:1977年至2005年麻省总医院的经验
Arch Surg. 2007 Apr;142(4):347-54. doi: 10.1001/archsurg.142.4.347.
10
Surgical treatment of non-functioning pancreatic islet cell tumors.无功能性胰岛细胞瘤的外科治疗
J Surg Oncol. 2005 Mar 1;89(3):170-85. doi: 10.1002/jso.20178.

偶然发现的无功能胰腺内分泌肿瘤的影响:患者的短期和长期预后

Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes.

作者信息

Haynes Alex B, Deshpande Vikram, Ingkakul Thun, Vagefi Parsia A, Szymonifka Jackie, Thayer Sarah P, Ferrone Cristina R, Wargo Jennifer A, Warshaw Andrew L, Fernández-del Castillo Carlos

机构信息

Department of Surgery, Massachusetts General Hospital, Wang Ambulatory Care Center 460, 15 Parkman St, Boston, MA 02114, USA.

出版信息

Arch Surg. 2011 May;146(5):534-8. doi: 10.1001/archsurg.2011.102.

DOI:10.1001/archsurg.2011.102
PMID:21576607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3688044/
Abstract

OBJECTIVES

To describe the characteristics and outcomes after resection of incidentally discovered, nonfunctioning pancreatic endocrine tumors (PETs).

DESIGN

Case series.

SETTING

Academic hospital.

PATIENTS

Consecutive patients with an incidentally identified, nonfunctioning PET resected from May 1, 1977, through July 31, 2009.

MAIN OUTCOME MEASURES

Operative morbidity and survival after resection.

RESULTS

A total of 139 patients with median age of 56 years (range, 21-85 years) underwent resection; tumor size ranged from 0.4 to 17.0 cm, with median size of 3.0 cm. No perioperative deaths were reported. Sixty-one patients (43.9%) experienced a perioperative complication. Twenty-six tumors (18.7%) were classified as benign, 39 (28.1%) as malignant, and 72 (51.8%) as uncertain. We were unable to confidently classify 2 tumors due to lack of information regarding mitotic rate in the pathology report. Complete follow-up was available for 112 patients (80.6%) (median, 34.2 months). Five-year actuarial survival rates were 88.8% for patients with benign disease, 92.5% for patients with tumors of uncertain biology, and 49.8% for those with malignant tumors (P = .01). Late metastasis, tumor recurrence, or disease progression were seen in 1 patient (3.8%) with tumors initially classified as benign, 8 patients (11.1%) with uncertain tumors, and 15 patients (38.5%) with tumors classified as malignant (P < .001). Of the 39 patients with tumors 2 cm or smaller, 3 (7.7%) had late metastases or recurrence. When compared with patients with symptomatic, nonfunctioning PETs, no large difference was observed in tumor size, patient age, disease, or survival.

CONCLUSIONS

Incidentally detected, nonfunctioning PETs can display aggressive behavior, even when small. Although patients with malignant disease had diminished survival and increased rates of recurrence, benign histologic findings did not eliminate the possibility of progression. Patients with incidentally discovered, nonfunctioning PETs should undergo tumor resection and careful postoperative surveillance, even if surgical pathologic findings suggest benign disease.

摘要

目的

描述偶然发现的无功能性胰腺内分泌肿瘤(PETs)切除术后的特征及结果。

设计

病例系列研究。

地点

学术型医院。

患者

1977年5月1日至2009年7月31日期间连续入选的偶然发现的无功能性PETs患者,均接受了手术切除。

主要观察指标

切除术后的手术并发症及生存率。

结果

共有139例患者接受了手术切除,中位年龄56岁(范围21 - 85岁);肿瘤大小为0.4至17.0 cm,中位大小为3.0 cm。未报告围手术期死亡病例。61例患者(43.9%)出现围手术期并发症。26个肿瘤(18.7%)被分类为良性,39个(28.1%)为恶性,72个(51.8%)为不确定。由于病理报告中缺乏有丝分裂率的信息,我们无法确定分类2个肿瘤。112例患者(80.6%)获得了完整随访(中位随访时间34.2个月)。良性疾病患者的5年精算生存率为88.8%,生物学行为不确定的肿瘤患者为92.5%,恶性肿瘤患者为49.8%(P = 0.01)。最初分类为良性的肿瘤患者中有1例(3.8%)出现晚期转移、肿瘤复发或疾病进展,生物学行为不确定的肿瘤患者中有8例(11.1%),分类为恶性的肿瘤患者中有15例(38.5%)(P < 0.001)。在39例肿瘤直径2 cm或更小的患者中,3例(7.7%)出现晚期转移或复发。与有症状的无功能性PETs患者相比,在肿瘤大小、患者年龄、疾病或生存率方面未观察到显著差异。

结论

偶然发现的无功能性PETs即使体积小也可能表现出侵袭性。虽然恶性疾病患者生存率降低且复发率增加,但良性组织学结果并不能排除疾病进展的可能性。偶然发现的无功能性PETs患者即使手术病理结果提示为良性疾病,也应接受肿瘤切除及仔细的术后监测。